Log In
Print
BCIQ
Print
Print this Print this
 

Ventana ALK (D5F3) Rabbit Monoclonal Primary Antibody assay

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionFully automated and standardized immunohistochemistry (IHC) test
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationCancer, Diagnostic
Indication DetailsDetecting HER protein expression in cancer patients who may be candidates for Kadcyla ado-trastuzumab emtansine (T-DM1), Perjeta pertuzumab or Herceptin trastuzumab treatment; To identify anaplastic lymphoma kinase (ALK)-positive patients among non-small cell lung cancer (NSCLC) patients
Regulatory Designation

Partner

Cell Signaling Technology Inc.; Pfizer Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today